Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National ...
A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
The Food and Drug Administration issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to ...
A recent study suggests that mindfulness-based stress reduction (MBSR) may be as effective as certain medications in ...
Thousands of bottles of a commonly prescribed antidepressant drug were recalled because they contained a suspected cancer-causing chemical.
Some anxiety medications can potentially worsen AFib symptoms. For example, healthcare professionals may avoid prescribing tricyclic antidepressants (TCAs) to individuals with heart conditions.
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a ...
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...
The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high ...
On October 11, the recall was classified as a class II recall by the FDA—a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health ...